|

18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2023-08-23
Est. completion2027-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06549413

Summary

This study is being done to learn how 18F-FSPG PET/CT scan results may be related to the response to chemotherapy and radiation in patients with esophageal cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* \* ≥ 18 years of age

  * Patients with locally advanced esophageal cancer
  * Patients with untreated documented carcinoma of the esophagus that is \> 2 cm who are going to receive systemic therapy concurrently with radiation as primary therapy
  * Ability to provide written informed consent in accordance with institutional policies
  * Female subjects of childbearing potential must have a negative serum or urine pregnancy test within 1 week of the proposed investigational PET/CT scan(s) prior to injection of the investigational radiopharmaceutical

Exclusion Criteria:

* \* Body weight ≥ 400 pounds or body habitus or disability that will not permit the imaging protocol to be performed

  * Pregnant or lactating females
  * Have an allergy to intravenous contrast
  * eGFR \< 30

Conditions2

CancerEsophageal Carcinoma

Locations1 site

M D Anderson Cancer Center
Houston, Texas, 77030
Steven H. Lin, MD, PHD713-563-2300shlin@mdanderson.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.